NCT04210037 2022-07-12
Study of APG-1252 Plus Paclitaxel in Patients With Relapsed/Refractory Small Cell Lung Cancer
Ascentage Pharma Group Inc.
Phase 1/2 Terminated
Ascentage Pharma Group Inc.
Western Regional Medical Center
UNC Lineberger Comprehensive Cancer Center